Selected References:
1. Rhodiola Rosea: A Phytomedicinal Overview. Richard P. Brown, M.D., Patricia L. Gerbarg, M.D., Zakir Ramazanov,Ph.D. American Botanical Council Herbalgram. 2002;56:40-52
2. C Germano & Z Ramazanov. Arctic Root (Rhodiola Rosea) The Powerful New Ginseng Alternative. Kensington Books NY, USA. 1999.
3. Darbinyan V et al. Rhodiola rosea in stress induced fatigue: a double blind crossover study of a standardized extract SHR-5 with repeated low dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine. 2000 Oct; 7(5): 365-371.
4. A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. AA, Wikman GK, Mandrikov VB, Mironova IA, Neumoin VV (Volgograd Spasov Medical Academy, Russia.)
5. Monograph: Rhodiola rosea. Altern Med Rev. 2002; 7(5): 421-423.
6. DeBock K et al. Acute Rhodiola intake can improve endurance exercise performance. Int J Sport Nutr Exerc Metab. 2004 Jun; 14(3): 298-307.
7. Shevtsov VA et al. A randomized trial of two different doses of SHR-5 Rhodiola rosea extract verses placebo and control of capacity for mental work. Phytomedicine. 2003 Mar; 10(2-3): 95-105.
8. Effect of extracts from Rhodiola rosea and Rhodiola crenulata roots on ATP content in mitochondria of skeletal muscles. Abidov M, Crendal F, Grachev S, Seifulla R, Ziegenfuss T. Institute of Immunopathology, Russian Academy of Natural Sciences, Moscow. Bull Exp Biol Med. 2003 Dec;136(6):585-7. PMID: 15500079
9. In vitro protective effect of Rhodiola rosea extract against hypochlorous acid-induced oxidative damage in human erythrocytes. De Sanctis R, De Bellis R, Scesa C, Mancini U, Cucchiarini L, Dacha M. Istituto di Chimica Biologica "Giorgio Fornaini", Universita degli Studi di Urbino "Carlo Bo", Urbino (PU), Italy. Biofactors. 2004;20(3):147-59. PMID: 15665385
10. Alternative Therapies in Psychiatry. Brown RP, Gerbarg PG, Muskin PR. Tasman A, Lieberman J, Kay J, editors. Psychiatry. 2nd ed. West Sussex, England: Wiley & Sons, Ltd.; 2002.
11. Szegedi A, Kohnen R, Dienel A, Kieser M. Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine. British Medical Journal 2005 Feb.
12. Fava M, Alpert J, Nierenberg AA, Mischoulon D, et al. A double-blind, randomized trial of St. John's wort, fluoxetine, and placebo in major depressive disorder. J Clin Psychopharmacol 2005 Oct;25(5):441-7.
13. Gastpar M, Singer A, Zeller K. Efficacy and tolerability of hypericum extract STW3 in long-term treatment with a once-daily dosage in comparison with sertraline. Pharmacopsychiatry 2005 Mar;38(2):78-86.
14. Kasper S, Dienel A. Cluster analysis of symptoms during antidepressant treatment with Hypericum extract in mildly to moderately depressed out-patients. A meta-analysis of data from three randomized, placebo-controlled trials. Psychopharmacology (Berl) 2002 Nov;164(3):301-8.
15. Schulz V. Clinical trials with hypericum extracts in patients with depression--results, comparisons, conclusions for therapy with antidepressant drugs. Phytomedicine 2002 Jul;9(5):468-74.
16. Lecrubier Y, Clerc G, Didi R, Kieser M. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial. Am J Psychiatry 2002 Aug;159(8):1361-6.
17. Friede M, Henneicke von Zepelin HH, Freudenstein J. Differential therapy of mild to moderate depressive episodes (ICD-10 F 32.0; F 32.1) with St. John's wort. Pharmacopsychiatry 2001 Jul;34 Suppl 1:S38-41.
18. Brenner R, Azbel V, Madhusoodanan S, Pawlowska M. Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study. Clinical Therapeutics 2000 Apr;22(4):411-9.
19. Kobayashi K, Nagato Y, Aoi N, Juneja LR, Kim M, et al. Effects of L-theanine on the release of a-brain waves in human volunteers. Nippon Nogeikagaku Kaishi. 1998;72:153-7.
20. Ueda T, Nagato Y, Tanaka Y, Okubo T, Kobayashi K, et al. Composition comprising theanine. US Patent 6,589,566; July 8, 2003.
21. Nakamura K, Sato T, Ohashi A, Tsurui H, Hasegawa H. Role of a serotonin precursor in development of gut microvilli. Am J Pathol. 2008 Feb;172(2):333-44. Epub 2008 Jan 17.
22. Fox MA, Jensen CL, Gallagher PS, Murphy DL. Receptor mediation of exaggerated responses to serotonin-enhancing drugs in serotonin transporter (SERT)-deficient mice. Neuropharmacology. 2007 Oct;53(5):643-56. Epub 2007 Jul 27.
23. Khaliq S, Haider S, Ahmed SP, Perveen T, Haleem DJ. Relationship of brain tryptophan and serotonin in improving cognitive performance in rats. Pak J Pharm Sci. 2006 Jan;19(1):11-5.
24. Perveen T, Zehra SF, Haider S, Akhtar N, Haleem DJ. Effects of 2 hrs. restraint stress on brain serotonin metabolism and memory in rats. Pak J Pharm Sci. 2003 Jan;16(1):27-33.
25. Balch, Phyllis A., James F. "Amino Acids." Prescription for Nutritional Healing. Ed. Amy C. Tecklenberg. New York, NY: Penguin Putnam Inc., 3rd Ed. 2000. 42-53.
26. Tyrosine (and N-Acetyl-L-Tyrosine) [PDF, 232KB] Reform Magazine online John M. Berardi
27. Dopaminergic deficit and mood disorders. Int Clin Psychopharmacol. 2002 Dec;17 Suppl 4:S1-7; discussion S7 Pania L, Gessab GL
28. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology. 2005;52(2):90-110. Epub 2005 Jul 19 Willner P
29. Tyrosine for the treatment of depression. Nutr Health. 1984;3(3):163-73 Gelenberg AJ, Gibson CJ
30. Tyrosine improves cognitive performance and reduces blood pressure in cadets after one week of a combat training course. Brain Res Bull. 1999 Jan 15;48(2):203-9 Deijen JB, Wientjes CJ, Vullinghs HF, Cloin PA, Langefeld JJ.
31. Dharmananda S. The nature of ginseng: traditional use, modern use, and the question of dosage. Herbalgram 2002;54:34-51.
32. Keum YS, Park KK, Lee JM, et al. Antioxidant and anti-tumor promoting activities of the methanol extract of heat-processed ginseng. Cancer Lett 2000;150:41-8.
33. Shin HR, Kim JY, Yun TK, et al. The cancer-preventive potential of Panax ginseng: a review of human and experimental evidence. Cancer Causes Control 2000;11:565-76
34. Kim YK, Guo Q, Packer L. Free radical scavenging activity of red ginseng aqueous extracts. Toxicology 2002;172:149-56.
35. Scaglione F, Cattaneo G, Alessandria M, Cogo R. Efficacy and safety of the standardized Ginseng extract G115 for potentiating vaccination against the influenza syndrome and protection against the common cold. Drugs Exp Clin Res 1996;22:65-72.
36. Brown R. Potential interactions of herbal medicines with antipsychotics, antidepressants and hypnotics. Eur J Herbal Med 1997;3:25-8. 18 Ibid
37. Bone K. Clinical Applications of Ayurvedic and Chinese Herbs. Queensland, Australia: Phytotherapy Press, 1996, 137–41.
38. Wagner H, Nörr H, Winterhoff H. Plant adaptogens. Phytomed 1994;1:63–76.
39. Bhattacharya SK, Kumar A, Ghosal S. Effects of glycowithanolides from Withania somnifera on an animal model of Alzheimer’s disease and perturbed central cholinergic markers of cognition in rats. Phytother Res 1995;9:110–3.
40. Mills and Bone, Principles and Practice of Phytotherapy (London: Churchill Livingston, 2000), 595-601.
41. ICON Health Publications. Ashwagandha - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References. 2004.
42. Stough C, Lloyd J, Clarke J, et al. The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology 2001;156:481-4.
43. Bhattacharya SK, Ghosal S. Anxiolytic activity of a standardized extract of Bacopa monniera in an experimental study. Phytomedicine 1998;5:77-82.
44. Elangovan V, Govindasamy S, Ramaoorthy N, Balasubramanian K. In vitro studies on the anti cancer activity of Bacopa monniera. Fitoterapia 1995; 66; 211-215.
45. Vohara D, Pal SN, Pillai KK. Protection from phenytoin-induced cognitive deficitby Bacopa monniera, a reputed Indian nootropic plant. Ethnopharmacol 2000;71;383-390.
46. WHO (1999): Folium Ginkgo: WHO Monographs on Selected Medicinal Plants. Geneva, World Health Organization, 1, pp 154-67.
47. Robbers James E. and Tyler Varro E. (1999): Tyler's Herbs of Choice: The Therapeutic Use of Phytomedicinals. New York, The Haworth Herbal Press, Inc.
48. Sierpina V. S., Wollschlaeger B. and Blumenthal M. (2003): Ginkgo biloba. Am Fam Physician. 68(5): 923-6.
49. Birks J and Grimley Evans J. (2004): Ginkgo biloba for cognitive impairment and dementia (Cochrane Review): The Cochrane Library, Issue 1. Chichester, UK, John Wiley & Sons, Ltd., pp 50.
50. Nathan PJ, Harrison BJ, Bartholomeusz C, Arnold KR, Wheatley D, Cheuvront SN, Carter R, III, Doraiswamy PM, Pomara N, Solomon PR et al. (2003): Ginkgo and memory... Solomon PR, Adams F, Silver A et al. Ginkgo for memory enhancement: a randomized controlled trial. JAMA. 2002;288:835-840. JAMA: Journal of the American Medical Association. 289(5): 546-548.
51. Solomon P. R., Adams F., Silver A., Zimmer J. and DeVeaux R. (2002): Ginkgo for memory enhancement: a randomized controlled trial. Jama. 288(7): 835-40.
52. Scholey A. B. and Kennedy D. O. (2002): Acute, dose-dependent cognitive effects of Ginkgo biloba, Panax ginseng and their combination in healthy young volunteers: differential interactions with cognitive demand. Hum Psychopharmacol. 17(1): 35-44.
53. Bascom Angella (2002): Incorporating Herbal Medicine into Clinical Practice. Philadelphia, F.A.Davis Company
54. Foster S. Herbs for Your Health. Loveland, CO: Interweave Press, 1996, 6–7.
55. Akhondzadeh S, Naghavi HR, Vazirian M, Shayeganpour A, Rashidi H, Khani M. Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther. 2001 Oct;26(5):363-7.
56. Dhawan K, Kumar S, Sharma A. Suppression of alcohol-cessation-oriented hyper-anxiety by the benzoflavone moiety of Passiflora incarnata Linneaus in mice. J Ethnopharmacol. 2002 Jul;81(2):239-44.
57. Akhondzadeh S, Kashani L, Mobaseri M, Hosseini SH, Nikzad S, Khani M. Passionflower in the treatment of opiates withdrawal: a double-blind randomized controlled trial. J Clin Pharm Ther. 2001 Oct;26(5):369-73. |